Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038187 (
starvation
)
24,951
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The full-length cDNA clone of a novel
GRP78-binding protein
(
GBP
) was isolated from rat brain using PCR-selected cDNA subtraction.
GBP
was predominantly expressed in neuronal cells among various brain tissues.
GBP
mRNA was already detected in the E12 brain and then gradually increased to reach a peak within P0-2 weeks after birth.
GBP
expression in the brain decreased age-dependently to approximately 30% of the postnatal level at 12 months.
GBP
encoded 1021 amino acids and was predicted to have two transmembrane regions and glutamic acid- and proline-rich regions. Because the sequence of
GBP
offered few clues to the possible function, we performed a GST-tagged
GBP
pull-down assay in PC12 lysates and identified GRP78, one of the heat shock proteins, as a counterpart. Observation of COS7 cells expressing green fluorescent protein- or Myc-tagged
GBP
showed that
GBP
was localized in the endoplasmic reticulum-Golgi domain where BODIPY 558/568 (4,4-difluro-5-(2-thienyl)-4-bora-3alpha,4alpha-diaza-S-indacene)-labeled brefeldin A accumulated. To investigate a biological role for
GBP
, we established Neuro2a cells stably expressing Myc-tagged
GBP
. Overexpression of
GBP
did not affect cell growth or morphological features but attenuated the time-dependent decrease in cell viability caused by serum deprivation compared with control cells. After 48 h of serum
starvation
, Neuro2a cells overexpressing
GBP
were resistant to the cell death induced by serum withdrawal. These results suggest that
GBP
would have a relevant functional role in embryonic and postnatal development of the brain.
...
PMID:Cloning and characterization of a novel GRP78-binding protein in the rat brain. 1251 90
Transmembrane protein 132A
(
TMEM132A
) is a novel GRP78 binding protein that we recently discovered. However, the biological functions of
TMEM132A
are merely characterized because it does not encode any known structural domains. In this study, we down regulated intrinsic
TMEM132A
by RNA interference and identified a variety of genes that fluctuated during
TMEM132A
gene silencing using microarray analysis.
TMEM132A
-knockdown in Neuro2a cells caused neurite-like projection without any stimuli and enhanced the expression of ATF6 mRNA, an ER stress transducer, and GADD153 mRNA, a stress inducible gene. Under serum-deprived condition,
TMEM132A
-knockdown cells gradually retarded neurite-like projection and decreased cell viability. Moreover,
TMEM132A
knockdown markedly induced GADD153 expression due to serum
starvation
without affecting the level of cleaved caspase-3. Our data suggest that
TMEM132A
is an important factor of cell survival in regulating certain ER stress-related gene expression in neuronal cells.
...
PMID:Knockdown of transmembrane protein 132A by RNA interference facilitates serum starvation-induced cell death in Neuro2a cells. 2045 9
Transmembrane protein 132A
(
TMEM132A
) was first isolated from rat brain using PCR-selected cDNA subtraction, and it was found to be predominantly expressed in the brain. However, the transcriptional regulation of the
TMEM132A
gene has not been fully characterized. In this study, we characterized the promoter activity of the 880-bp region upstream of the mouse
TMEM132A
, identifying several putative sites recognized by transcription factors, which are highly conserved between the mouse and human
TMEM132A
genes. Using four different mouse cell lines (Neuro2a, NSC-34, NIH3T3, and Raw264.7), we first evaluated the intrinsic levels of
TMEM132A
mRNA and protein expression. Interestingly,
TMEM132A
mRNA was expressed in all four cell lines, whereas the protein was negligible in Raw264.7 cells even by transfection of
TMEM132A
gene. Then, we analyzed the
TMEM132A
promoter activity using serial deleted constructs, finding it was nearly same pattern in all four cell lines. A mutational analysis of the
TMEM132A
promoter identified a critical region for its activation just upstream of the transcriptional start site. Finally, we investigated the levels of
TMEM132A
mRNA and protein after exposure to five different neurotoxic stimuli, including thapsigargin, tunicamycin, serum
starvation
, homocysteine, and hydrogen peroxide. Treatment with thapsigargin, a calcium modulating agent, markedly attenuated the levels of
TMEM132A
mRNA and protein in NSC-34 cells. These results give new insight into the mechanisms involved in regulating
TMEM132A
expression, and suggest that several transcriptional and post-transcriptional pathways regulate
TMEM132A
expression under developmental and pathophysiological conditions.
...
PMID:Transcriptional and post-transcriptional regulation of transmembrane protein 132A. 2592 56